-
The Diagnostic Spectrum of Sexual Hallucinations. Harv. Rev. Psychiatry (IF 3.8) Pub Date : 2024-1-5 Jan Dirk Blom, Rosemarij J B van Veen, Emma H C van Rooijen, Christina W Slotema
Sexual hallucinations are little known, yet often extremely burdening, phenomena. In this systematic review, we summarize what is known about their phenomenology, prevalence, etiopathology, ensuing distress, and treatment options. Sexual hallucinations can be experienced as genital or orgasmic sensations, although other sensory modalities can also be involved. With the notable exception of orgasmic
-
On the Classification and Reporting of Prolonged Grief: Assessment and Research Guidelines. Harv. Rev. Psychiatry (IF 3.8) Pub Date : 2024-1-5 Margaret S Stroebe, Henk A W Schut, Maarten C Eisma
• Explain the steps required for diagnosis of mental disorders in diagnostic handbooks.• Identify current procedures for classifying and reporting prolonged grief disorder.
-
The Tarnished Legacy of a Wonder Drug: Revisiting the Complicated History of Clozapine. Harv. Rev. Psychiatry (IF 3.8) Pub Date : 2024-1-5 Roshan Poudel, Barron Lerner
Anecdotal evidence of superior efficacy and lack of extrapyramidal symptoms in treating schizophrenia made clozapine a promising therapy in the United States during the early 1970s. In 1975, however, numerous fatal cases of clozapine-related agranulocytosis in Finland nearly ended the drug's development. Convinced of the significant benefits to patients, some clinicians in the United States advocated
-
Toward a Psychological Model of Chemical Coping with Opioids in Cancer Care. Harv. Rev. Psychiatry (IF 3.8) Pub Date : 2023-11-10 Miryam Yusufov, William F Pirl, Ilana M Braun, Timothy Sannes, R Kathryn McHugh
• Outline the risk factors involved with opioid accessibility in patients receiving treatment for cancer.• Identify factors to address in order to mitigate risk for opioid misuse during cancer care.
-
Mental Health Is Heart Health: Adjusting Clinical Guidelines for Depression After Myocardial Infarction. Harv. Rev. Psychiatry (IF 3.8) Pub Date : 2023-10-24 Christian R Hardoy,Jonathan H Shipley,Eric N Kramer,Robert M McCarron
-
Use of First-Generation Antipsychotics in an Adolescent Male with Catatonic Schizophrenia. Harv. Rev. Psychiatry (IF 3.8) Pub Date : 2023-10-13 Emmy Masur Patterson,Jacqueline Lim,Paul Fuchs,Joshua R Smith,Alexandra Moussa-Tooks,Heather Burrell Ward
-
Hero or Antagonist: A Case Series on the Tolerability of Memantine as Salvage Therapy for Catatonia from Anti-NMDA Receptor Encephalitis. Harv. Rev. Psychiatry (IF 3.8) Pub Date : 2023-10-13 Jennifer Wang,Samir J Abu-Hamad,Michael Jennings,Kyle Blackburn,Diana M Robinson
-
Potential Role of Smartphone Technology in Advancing Work on Neurological Soft Signs with a Focus on Schizophrenia. Harv. Rev. Psychiatry (IF 3.8) Pub Date : 2023-9-12 Lucy E Gray, Robert W Buchanan, Matcheri S Keshavan, John Torous
• Outline and Identify potential benefits of using neurological soft signs (NSS) as biomarkers of schizophrenia.
-
A Grave Set of Diagnoses: A Case of Mania with Comorbid Autoimmune Thyroiditis Precipitated by Multiple Sclerosis Treatment. Harv. Rev. Psychiatry (IF 3.8) Pub Date : 2023-08-22 Han Yue,Sejal B Shah,Katherine L Modzelewski,Mark Knobel,Frank Copeli,Larkin Kao
-
Beyond Epistemic Injustice: When Perceived Realities Conflict. Harv. Rev. Psychiatry (IF 3.8) Pub Date : 2023-07-28 Rajvinder Samra
-
A 23-Year-Old Woman with Psychotic Mania and a Report of Sexual Violence During a Psychiatric Hospitalization. Harv. Rev. Psychiatry (IF 3.8) Pub Date : 2023-07-28 Kati N Lake,Victoria M Wilkins,Elizabeth B Ford,Sharon J Parish,Reile M Slattery,Mark J Russ,Benjamin D Brody
-
Status of Type II vs. Type I Bipolar Disorder: Systematic Review with Meta-Analyses. Harv. Rev. Psychiatry (IF 3.8) Pub Date : 2023-7-12 Carolina V Hernandorena, Ross J Baldessarini, Leonardo Tondo, Gustavo H Vázquez
• Analyze and compare the different bipolar disorder (BD) types.• Identify markers that distinguish BD types and explain how the DSM-IV defines the disorder.
-
Psychopharmacological Considerations for Gender-Affirming Hormone Therapy. Harv. Rev. Psychiatry (IF 3.8) Pub Date : 2023-7-12 Hyun-Hee Kim, Teddy G Goetz, Victoria Grieve, Alex S Keuroghlian
The field of transgender health has grown exponentially since the early 2010s. While this increased visibility has not been without controversy, there is growing acknowledgement of the needs of transgender, nonbinary, and gender expansive (TNG) patients and the health disparities they experience compared to the cisgender population. There is also increased interest among clinicians and trainees in
-
Making an MPCT: Building and Sustaining a Multicultural Psychology Consultation Team (MPCT) Within an Academic Medical Center. Harv. Rev. Psychiatry (IF 3.8) Pub Date : 2023-7-12 Stephanie Pinder-Amaker, Jeffrey P Winer, Lauren P Wadsworth, Caitlin M Nevins, Andrew Peckham, Jacob A Nota, Courtney Beard
The synergistic epidemics of COVID-19, racial injustice, and health inequities sparked an unprecedented commitment from US hospital systems and treatment settings to address health disparities by increasing access to care for historically oppressed and underserved communities. However, the inability of hospital systems to actually provide multiculturally responsive care and, more broadly, to consistently
-
Should Medical Insurance Review Serve the Patient's Best Interests? Examples and Considerations Illustrated by Behavioral Health Cases. Harv. Rev. Psychiatry (IF 3.8) Pub Date : 2023-7-12 Peter Q Harris, Melissa E Abraham, Bruce M Cohen
Physician medical directors working for health care insurance companies conduct utilization reviews, participate in quality-of-care reviews, and adjudicate appeals. As a result, they have access to substantial and important clinical information. The medical director may have both current and historical information that can assist the treatment team in providing care. Sharing this information with a
-
Sodium-Glucose Cotransporter-2 Inhibitors in Depression. Harv. Rev. Psychiatry (IF 3.8) Pub Date : 2023-7-12 David T Liebers, Wataru Ebina, Dan V Iosifescu
Novel treatment strategies that refract existing treatment algorithms for depressive disorders are being sought. Abnormal brain bioenergetic metabolism may represent an alternative, therapeutically targetable neurobiological basis for depression. A growing body of research points to endogenous ketones as candidate neuroprotective metabolites with the potential to enhance brain bioenergetics and improve
-
Electroconvulsive Therapy: Mechanisms of Action, Clinical Considerations, and Future Directions Harv. Rev. Psychiatry (IF 3.8) Pub Date : 2023-05-01 Michael D. Kritzer, Angel V. Peterchev, Joan A. Camprodon
Learning objectives: • Outline and discuss the fundamental physiologic, cellular, and molecular mechanisms of ECT to devise strategies to optimize therapeutic outcomes • Summarize the overview of ECT, its efficacy in treating depression, the known effects on cognition, evidence of mechanisms, and future directions. Electroconvulsive therapy (ECT) is the most effective treatment for a variety of psychiatric
-
Accelerated Repetitive Transcranial Magnetic Stimulation to Treat Major Depression: The Past, Present, and Future Harv. Rev. Psychiatry (IF 3.8) Pub Date : 2023-05-01 Leo Chen, Deborah C. W. Klooster, Martin Tik, Elizabeth H. X. Thomas, Jonathan Downar, Paul B. Fitzgerald, Nolan R. Williams, Chris Baeken
Abstract: Repetitive transcranial magnetic stimulation (rTMS) is an effective and evidence-based therapy for treatment-resistant major depressive disorder. A conventional course of rTMS applies 20–30 daily sessions over 4–6 weeks. The schedule of rTMS delivery can be accelerated by applying multiple stimulation sessions per day, which reduces the duration of a treatment course with a predefined number
-
Photobiomodulation for Major Depressive Disorder: Linking Transcranial Infrared Light, Biophotons and Oxidative Stress Harv. Rev. Psychiatry (IF 3.8) Pub Date : 2023-05-01 Willians Fernando Vieira, Maia Gersten, Marco Antonio Knob Caldieraro, Paolo Cassano
Incompletely treated major depressive disorder (MDD) poses an enormous global health burden. Conventional treatment for MDD consists of pharmacotherapy and psychotherapy, though a significant number of patients do not achieve remission with such treatments. Transcranial photobiomodulation (t-PBM) is a promising novel therapy that uses extracranial light, especially in the near-infrared (NIR) and red
-
Closed-Loop Deep Brain Stimulation for Psychiatric Disorders Harv. Rev. Psychiatry (IF 3.8) Pub Date : 2023-05-01 Alik S. Widge
Deep brain stimulation (DBS) is a well-established approach to treating medication-refractory neurological disorders and holds promise for treating psychiatric disorders. Despite strong open-label results in extremely refractory patients, DBS has struggled to meet endpoints in randomized controlled trials. A major challenge is stimulation “dosing”—DBS systems have many adjustable parameters, and clinicians
-
The Impact of Sex Hormones on Transcranial Magnetic Stimulation Measures of Cortical Excitability: A Systematic Review and Considerations for Clinical Practice Harv. Rev. Psychiatry (IF 3.8) Pub Date : 2023-05-01 Ana Maria Rivas-Grajales, Tracy Barbour, Joan A. Camprodon, Michael D. Kritzer
Repetitive transcranial magnetic stimulation (rTMS) has emerged as a promising alternative for the treatment of major depressive disorder (MDD), although its clinical effectiveness varies substantially. The effects of sex hormone fluctuations on cortical excitability have been identified as potential factors that can explain this variability. However, data on how sex hormone changes affect clinical
-
Co-Occurring Autism Spectrum and Borderline Personality Disorder: An Emerging Clinical Challenge Seeking Informed Interventions. Harv. Rev. Psychiatry (IF 3.8) Pub Date : 2023-03-09 Lukas Cheney,Robert B Dudas,Jenna M Traynor,Josephine A Beatson,Sathya Rao,Lois W Choi-Kain
-
Applications of Speech Analysis in Psychiatry: Erratum. Harv. Rev. Psychiatry (IF 3.8) Pub Date : 2023-03-09
-
Why Don't You Take This to a Friend? A Question Psychotherapists Should Ask More Often. Harv. Rev. Psychiatry (IF 3.8) Pub Date : 2023-03-09 Jacqueline Olds,Richard S Schwartz
-
Remembering Paul E. Meehl: Historical Contributions to Predictive Modeling in Human Behavior Harv. Rev. Psychiatry (IF 3.8) Pub Date : 2023-03-01 Jihan Ryu
This article briefly examines the life and work of the late clinical psychologist and philosopher of science Paul E. Meehl. His thesis in Clinical versus Statistical Prediction (1954) that the data combination performed by mechanical operations, as compared to clinicians, achieves higher accuracy in predicting human behavior is one of the earliest theoretical works that laid the groundwork for utilizing
-
Evidence-Based Mind-Body Interventions for Children and Adolescents with Functional Neurological Disorder Harv. Rev. Psychiatry (IF 3.8) Pub Date : 2023-03-01 Kasia Kozlowska, Catherine Chudleigh, Blanche Savage, Clare Hawkes, Stephen Scher, Kenneth P. Nunn
Learning objectives • Develop and implement treatment plans for children and adolescents with functional neurological disorder (FND) • Outline a plan to increase awareness and standardize the care for patients with FND using evidence-based interventions Functional neurological disorder (FND) in children and adolescents involves the biological embedding of lived experience in the body and brain. This
-
Hikikomori Syndrome and Digital Technologies: A Systematic Review Harv. Rev. Psychiatry (IF 3.8) Pub Date : 2023-03-01 Gabriel S. Sales-Filho, Igor D. Bandeira, Nayara Argollo, Rita Lucena
Hikikomori syndrome (HS) is a voluntary prolonged social isolation associated with personal and community impact. Previous evidence pointed out a possible relationship between this syndrome with addiction to digital technologies. Here we aim to understand the relationship between HS and digital technology use, overuse, and addictive behaviors, as well as potential therapeutic approaches. We conducted
-
Applications of Speech Analysis in Psychiatry. Harv. Rev. Psychiatry (IF 3.8) Pub Date : 2023-1-7 Katerina Dikaios, Sheri Rempel, Sri Harsha Dumpala, Sageev Oore, Michael Kiefte, Rudolf Uher
The need for objective measurement in psychiatry has stimulated interest in alternative indicators of the presence and severity of illness. Speech may offer a source of information that bridges the subjective and objective in the assessment of mental disorders. We systematically reviewed the literature for articles exploring speech analysis for psychiatric applications. The utility of speech analysis
-
Challenges of Agitation in Dementia: A Plea for Early Discussion. Harv. Rev. Psychiatry (IF 3.8) Pub Date : 2023-1-7 Leah G Richler, Mariko Shimizu, Hsiang Huang, Rachel Kester
Behavioral and psychological symptoms of dementia (BPSD) occur frequently among people with dementia and are known precipitants for placement in care facilities. Despite the social, financial, and psychological impact on dementia care, education and discussions on BPSD have not been routinely included in advance care planning (ACP). As a result, families can face great challenges in making complex
-
Psychotic Misdiagnosis of Racially Minoritized Patients: A Case-Based Ethics, Equity, and Educational Exploration. Harv. Rev. Psychiatry (IF 3.8) Pub Date : 2023-1-7 Anita M Jegarl, Oluwole Jegede, Jessica Isom, Nicole Ciarleglio, Carmen Black
The overdiagnosis and misdiagnosis of racially minoritized groups as having a primary psychotic disorder is one of psychiatry's longest-standing inequities born of real-time clinician racial bias. Evidence suggests that providers assign a diagnosis of schizophrenia and/or schizoaffective disorder according to race more than any other demographic variable, and this inequity persists even in the absence
-
Clinical Implications of the Neurosteroid Allopregnanolone in Reproductive Depression. Harv. Rev. Psychiatry (IF 3.8) Pub Date : 2023-1-7 Leah C Susser
Certain women develop depression with fluctuations in hormone levels whereas other women do not; this hormonally driven depression has been termed reproductive depression. The pathophysiology of reproductive depression differs from that of major depressive disorder, and this distinction has important clinical-including treatment-implications. Recent advances have revealed that the neurosteroid, allopregnanolone
-
Exploring a Multidisciplinary Approach to Wernicke's Encephalopathy in Pregnancy. Harv. Rev. Psychiatry (IF 3.8) Pub Date : 2023-01-01 Rachel Belfer,Alexandra Fields,Rafael Gonzalez-Alonso,Carolyn Sargent,Rubiahna L Vaughn,Aviva Caroff,Eric J Mariuma,Ketevan Amirkhanashvili,Runjhun Bhatia,Andrea Murez
-
A Case of Functional Cognitive Disorder: Psychotherapy and Speech and Language Therapy Insights. Harv. Rev. Psychiatry (IF 3.8) Pub Date : 2023-01-01 Ellen J Godena,Jennifer L Freeburn,Noah D Silverberg,David L Perez
-
Treatment of Amphetamine-Induced Truman Show Delusion and Delusional Parasitosis with High-Dose Ziprasidone. Harv. Rev. Psychiatry (IF 3.8) Pub Date : 2023-01-01 Ziad A Ali,Ben Sanders,Rif El-Mallakh,Melissa Mathews,Shawn Brown
-
Clinical and Ethical Dilemmas in the Involuntary Treatment of Anorexia Nervosa Harv. Rev. Psychiatry (IF 3.8) Pub Date : 2023-01-01 Jenny Tumba, Megan Smith, Kyle E. Rodenbach
Learning objectives After completing this activity, practitioners will be better able to: • Discuss the growing body literature emphasizing moderation and harm-reduction in patients with severe and enduring anorexia nervosa (SE-AN) • Outline and discuss the legal, ethical, and medical challenges inpatient providers face when treating patients with SE-AN Patients with severe and enduring anorexia nervosa
-
Unremitting Suicidality in Borderline Personality Disorder: A Single Case Study and Discussion of Technology in Clinical Care. Harv. Rev. Psychiatry (IF 3.8) Pub Date : 2022-12-20 Lois W Choi-Kain,Grace E Murray,Mark J Goldblatt,Chelsey R Wilks,Ipsit V Vahia,Daniel D L Coppersmith,Gabrielle S Ilagan,Boyu Ren
-
Methemoglobinemia in a Patent Presenting with an Undisclosed Intentional Overdose. Harv. Rev. Psychiatry (IF 3.8) Pub Date : 2022-12-20 Claire L Gibson,Sarah B Abdallah,Natalie R Neumann,Hun Millard,Sarah Riley
-
Structural and Functional Brain Alterations in Populations with Familial Risk for Depression: A Narrative Review Harv. Rev. Psychiatry (IF 3.8) Pub Date : 2022-11-01 Birce Begum Burhanoglu, Ali Saffet Gonul
Learning objectives After completing this activity, practitioners will be better able to: • Discuss the association between brain alterations and vulnerability or resilience to MDD in people with familial risk • Define how structural and functional brain alterations associated with vulnerability or resilience could lead to a better understanding of the pathophysiology of MDD Aim Familial history
-
(In)Equality and Beyond: Achieving Justice in Gender-Affirming Hormone Initiation Harv. Rev. Psychiatry (IF 3.8) Pub Date : 2022-11-01 Christina L. Macenski, Alex S. Keuroghlian, Christopher G. AhnAllen, Genny Beemyn, Eli Erlick, Jules Gill-Peterson, Joanna Marie Harper, Rebeca Ramos, Daphna Stroumsa, Fernando J. Benetti, John A. Fromson
The World Professional Association for Transgender Health (WPATH) is an international organization that aims to advocate for transgender and gender-diverse (TGD) people by promoting safe and effective ways to access and deliver healthcare to maximize psychological health and well-being. One way this is achieved is through the WPATH’s published Standards of Care for the Health of Transsexual, Transgender
-
From Alchemy to Psychiatry: A Glimpse into the Ethics and Mental Health Practices of Tenth-Century Muslim Physician Abū Bakr al-Rāzī. Harv. Rev. Psychiatry (IF 3.8) Pub Date : 2022-09-15 Rania Awaad,Yusif Salaam Conn,Nahlah Kolkailah,Heba El-Haddad,Sara Ali,Soraya Fereydooni
-
Men's Depression, Externalizing, and DSM-5-TR: Primary Signs and Symptoms or Co-occurring Symptoms? Harv. Rev. Psychiatry (IF 3.8) Pub Date : 2022-09-15 Simon Rice,Zac Seidler,David Kealy,John Ogrodniczuk,Ian Zajac,John Oliffe
-
Back to Basics: Lifestyle Interventions for Adolescent Depression Harv. Rev. Psychiatry (IF 3.8) Pub Date : 2022-09-01 Talia S. Benheim, Michelle Dalal, Juliana M. Holcomb, Anamika Dutta, Daniel Hosker, Michael S. Jellinek, J. Michael Murphy
Learning objectives After completing this activity, practitioners will be better able to: • Discuss and better understand the recently adopted screening standards for adolescents with depression and the potential advantages of using “lifestyle medicine” • Set up a process for providing effective interventions for the increased number of patients with adolescent depression • Design or update their
-
Malignant Self-Regard: Overview and Future Directions. Harv. Rev. Psychiatry (IF 3.8) Pub Date : 2022-7-19 Steven K Huprich, Brady C Malone
Malignant self-regard (MSR) is a self-representation that encompasses the shared features of depressive personality disorder, masochistic/self-defeating personality disorder, depressive-masochistic personality, and vulnerable narcissism. In this review we begin by describing the construct's historical precursors, which begin in early psychoanalytic/dynamic theory, and then trace its development across
-
Medical Mistrust in Perinatal Mental Health Harv. Rev. Psychiatry (IF 3.8) Pub Date : 2022-07-01 Nkechi Conteh, Jane Gagliardi, Shunda McGahee, Rose Molina, Crystal T. Clark, Camille A. Clare
Despite the advancement of telemedicine and recent innovations in treatment, minoritized women continue to bear a disproportionate burden of pregnancy-related psychiatric conditions and complications, which the pandemic has further exacerbated. Research demonstrates that medical mistrust and systemic racism play central roles in the underutilization of services by racially and ethnically diverse women
-
Adverse Childhood Experiences and Neurocognition in Borderline Personality Disorder: A Call-to-Action Perspective Review Harv. Rev. Psychiatry (IF 3.8) Pub Date : 2022-07-01 Clémentine Estric, Raffaella Calati, Jorge Lopez-Castroman
Adverse childhood experiences (ACEs) contribute to the development of personality traits leading to adult borderline personality disorder (BPD). Neurocognitive changes could partly mediate the association between ACEs and BPD. We discuss how exposure to ACEs could induce alterations in neurocognition, which, in turn, would contribute to the development of BPD. We conducted a review of MEDLINE articles
-
Menopausal Hormone Therapy and the Mind: The Role of Hormone Replacement in the Prevention and Treatment of Cognitive Decline, Dementia, and Cognitive Dysfunction of Depression Harv. Rev. Psychiatry (IF 3.8) Pub Date : 2022-07-01 Amanda Koire, Hadine Joffe, Rachel Buckley
Learning objectives After participating in this activity, learners should be better able to: • Outline the clinical recommendations for menopausal hormone treatment related to cognitive concerns • Debate and discuss the various research pieces on the use of menopausal hormone therapy cognitive decline, dysfunction, and dementia Menopause has been associated with subjective cognitive dysfunction and
-
Prevalence of Posttraumatic Stress Disorder Symptoms Following Traumatic Spinal Cord Injury: A Systematic Review and Meta-analysis. Harv. Rev. Psychiatry (IF 3.8) Pub Date : 2022-06-14 Mahmoud Yousefifard, Fatemeh Ramezani, Gholamreza Faridaalaee, Masoud Baikpour, Arian Madani Neishaboori, Alexander R Vaccaro, Mostafa Hosseini, Vafa Rahimi-Movaghar
Limited evidence is currently available on the prevalence of posttraumatic stress disorder (PTSD) following traumatic spinal cord injury (SCI). This systematic review and meta-analysis aims to assess the prevalence and geographic distribution of PTSD symptoms after SCI.
-
Neuromodulation Using Computer-Altered Music to Treat a Ten-Year-Old Child Unresponsive to Standard Interventions for Functional Neurological Disorder. Harv. Rev. Psychiatry (IF 3.8) Pub Date : 2022-05-26 Nadia Rajabalee,Kasia Kozlowska,Seung Yeon Lee,Blanche Savage,Clare Hawkes,Daniella Siciliano,Stephen W Porges,Susannah Pick,Souraya Torbey
-
The Long-Term Outcomes of Prepubertal Depression and Internalizing Problems: A Scoping Review Harv. Rev. Psychiatry (IF 3.8) Pub Date : 2022-05-01 Adam Sands, Milenna T. van Dijk, Eyal Abraham, Tenzin Yangchen, Ardesheer Talati, Myrna M. Weissman
Learning objectives After participating in this activity, learners should be better able to: • Discuss whether prepubertal depression shows longitudinal continuity with depression in adulthood. • Summarize existing literature on adult emotional and functional outcomes of prepubertal depression and internalizing problems. Background Adolescent- and young adult–onset depression are common, recurrent
-
An Integrated Neuroimaging Approach to Inform Transcranial Electrical Stimulation Targeting in Visual Hallucinations Harv. Rev. Psychiatry (IF 3.8) Pub Date : 2022-05-01 Nicolas Raymond, Robert M. G. Reinhart, Matcheri Keshavan, Paulo Lizano
For decades, noninvasive brain stimulation (NIBS), such as transcranial electrical stimulation (tES), has been used to directly modulate human brain mechanisms of visual perception, setting the groundwork for the development of novel circuit-based therapies. While the field of NIBS has grown considerably over recent years, few studies have used these technologies to treat visual hallucinations (VH)
-
The Practice of Psychiatric E-Consultation: Current State and Future Directions Harv. Rev. Psychiatry (IF 3.8) Pub Date : 2022-05-01 Thomas C. E. Adams, Christopher T. Lim, Hsiang Huang
Objective This article summarizes the existing literature on psychiatric electronic consultation (e-consultation or e-consult) to provide guidance on psychiatric e-consult practice and suggest next steps in research on psychiatric e-consults. Method A narrative review was conducted using relevant search terms in PubMed and Google Scholar. Results and Discussion The psychiatric e-consult is a method
-
Assessment and Treatment of a Deaf Patient with Alcohol Use Disorder-Limitations and Special Considerations. Harv. Rev. Psychiatry (IF 3.8) Pub Date : 2022-04-29 Ann Felhofer,Teresa Crowe,Christopher G AhnAllen,Lisa A Mistler,Joji Suzuki
-
Catatonia and Schizophrenia in a Young Man with Autism Spectrum Disorder and Clozapine-Induced Myocarditis Harv. Rev. Psychiatry (IF 3.8) Pub Date : 2022-04-15 Mohan Gautam,Mauran Sivananthan,Robert Cotes,Scott Beach
-
"Non-healing Wounds": Addressing Complex Physical and Emotional Trauma in a Case of Factitious Disorder. Harv. Rev. Psychiatry (IF 3.8) Pub Date : 2022-04-15 Cynthia S Peng,Amanda M Koire,Stuart Eisendrath,Joshua Abrams,Marc D Feldman,Carolina Jimenez-Madiedo
-
Suicide Prevention in Your Pocket: A Systematic Review of Ecological Momentary Interventions for the Management of Suicidal Thoughts and Behaviors Harv. Rev. Psychiatry (IF 3.8) Pub Date : 2022-03-01 Laura Jiménez-Muñoz, Inmaculada Peñuelas-Calvo, Isaac Díaz-Oliván, Luis Gutiérrez-Rojas, Enrique Baca-García, Alejandro Porras-Segovia
Background This study reviews the evidence on ecological momentary interventions (EMIs) for managing and preventing suicidal thoughts and behaviors. Methods This review follows the Preferred Reporting Items for Systematic Reviews and Meta-analyses guidelines. Its protocol was registered in the PROSPERO database. We conducted a systematic literature search of five databases: PubMed, EMBASE, Web of
-
Psychiatric Symptoms Across the Menstrual Cycle in Adult Women: A Comprehensive Review Harv. Rev. Psychiatry (IF 3.8) Pub Date : 2022-03-01 Ariel B. Handy, Shelly F. Greenfield, Kimberly A. Yonkers, Laura A. Payne
Learning objective After participating in this activity, learners should be better able to: • Discuss and outline the general and overlapping effects of the menstrual cycle on women’s mental health A growing body of research demonstrates menstrual cycle–dependent fluctuations in psychiatric symptoms; these fluctuations can therefore be considered as prevalent phenomena. Possible mechanisms underlying
-
Does Hippocampal Volume in Patients with Posttraumatic Stress Disorder Vary by Trauma Type? Harv. Rev. Psychiatry (IF 3.8) Pub Date : 2022-03-01 Cecilia A. Hinojosa
Posttraumatic stress disorder (PTSD) is a debilitating disorder that can develop after experiencing a traumatic event and is, in part, characterized by memory disturbances. Given its important role in learning and memory, the hippocampus has been studied extensively in PTSD using volumetric neuroimaging techniques. However, the results of these studies are mixed. The variability in findings across
-
Ketamine in the Treatment of Obsessive-Compulsive Disorder: A Systematic Review Harv. Rev. Psychiatry (IF 3.8) Pub Date : 2022-03-01 Igor D. Bandeira, Daniel H. Lins-Silva, Vitor Breseghello Cavenaghi, Ingrid Dorea-Bandeira, Daniela Faria-Guimarães, Judah L. Barouh, Ana Paula Jesus-Nunes, Graziele Beanes, Lucca S. Souza, Gustavo C. Leal, Gerard Sanacora, Euripedes C. Miguel, Aline S. Sampaio, Lucas C. Quarantini
Introduction First-line treatment for obsessive-compulsive disorder (OCD) includes exposure and response prevention behavioral therapy and serotonin reuptake inhibitors, particularly in combination. New and more effective treatments are needed, give that recent studies suggest that glutamatergic neurotransmission contributes to the pathophysiology of the disorder. In these circumstances, ketamine
-
The Computations of a Traumatized Mind: A Latent Cause Model of Posttraumatic Stress Disorder Harv. Rev. Psychiatry (IF 3.8) Pub Date : 2022-03-01 Francesco Rigoli
In cognitive psychology, a recent perspective based on the notion of latent cause (LC) has offered new insight on how learning and memory work. Here I explore the implications of this novel perspective to understand posttraumatic stress disorder (PTSD). The proposal is that, because of a propensity to interpret events as manifestations of multiple LCs (a propensity facilitated by experiencing traumas
-
Could Anti-inflammatory Interventions Earlier in Development Confer Primary Prevention of Psychiatric Disorders? Harv. Rev. Psychiatry (IF 3.8) Pub Date : 2022-01-08 Mantas Kazimieras Malys,Valeria Mondelli